PATENT CLAIM ANALYSIS

Application Number: 16224004
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "100000"]

Abstract:
In an aspect, the invention relates to compositions and methods for permeabilizing membranes of cells. In an aspect, the invention relates to compositions and methods for killing cells. In an aspect, the invention relates to compositions and methods of permeabilizing the membranes of cancer cells or microbial cells.

Claim (Index 7):
The method of  claim 1 , further comprising repeating the administration of the therapeutically effective amount of the composition comprising the CT20p peptide and the pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 2.57143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14717884', '14240801', '13478831', '11695321', '13393394']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7424727573070481
- 35 USC 102 Novelty (BERT): 0.543213625771435
- Combined Prediction Score: 0.7225468441534868
- Mean Citation Score: 272.88016000000005
- Max Citation Score: 386.19415
- Similarity Product: 344.2577389558196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test